© 2019 Next Science Limited - All Rights Reserved. Solution by MUFG Corporate Markets, a division of MUFG Pension & Market Services
Next Science Limited (ASX: NXS) is a medical technology company headquartered in Sydney, Australia, with commercial operations in Florida, USA. Next Science’s primary focus is the development and continued commercialisation of its proprietary XBIO™ technology to reduce the impact of biofilm-based infections in human health.
Next Science Limited
Level 14, Australia Square,
264-278 George Street, Sydney
NSW 2000
Ph: +61 412 292 977
E: [email protected]
Automic
Level 5, 126 Phillip Street
Sydney NSW 2000
Email: [email protected]
Ph (within Australia): 1300 288 664
Ph (outside Australia): +61 2 9698 5414
© 2019 Next Science Limited - All Rights Reserved. Solution by MUFG Corporate Markets, a division of MUFG Pension & Market Services